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The zeamines (zeamine, zeamine I, and zeamine II) constitute an unusual class of cationic polyamine-polyketide-nonribosomal
peptide antibiotics produced by Serratia plymuthica RVH1. They exhibit potent bactericidal activity, killing a broad range of
Gram-negative and Gram-positive bacteria, including multidrug-resistant pathogens. Examination of their specific mode of ac-
tion andmolecular target revealed that the zeamines affect the integrity of cell membranes. The zeamines provoke rapid release
of carboxyfluorescein from unilamellar vesicles with different phospholipid compositions, demonstrating that they can interact
directly with the lipid bilayer in the absence of a specific target. DNA, RNA, fatty acid, and protein biosynthetic processes ceased
simultaneously at subinhibitory levels of the antibiotics, presumably as a direct consequence of membrane disruption. The
zeamine antibiotics also facilitated the uptake of small molecules, such as 1-N-phenylnaphtylamine, indicating their ability to
permeabilize the Gram-negative outer membrane (OM). The valine-linked polyketide moiety present in zeamine and zeamine I
was found to increase the efficiency of this process. In contrast, translocation of the large hydrophilic fluorescent peptidoglycan
binding protein PBDKZ-GFP was not facilitated, suggesting that the zeamines cause subtle perturbation of the OM rather than
drastic alterations or defined pore formation. At zeamine concentrations above those required for growth inhibition, membrane
lysis occurred as indicated by time-lapse microscopy. Together, these findings show that the bactericidal activity of the zeamines
derives from generalized membrane permeabilization, which likely is initiated by electrostatic interactions with negatively
charged membrane components.
Bacterial secondary metabolites represent an enormous groupof natural products that do not play an essential role in normal
growth and development of an organism but confer a selective
advantage in certain ecological niches and complex microbial
communities (1). Production of thesemetabolites typically occurs
at the onset of stationary growth phase and may be triggered by
specific environmental stimuli. Because of their structural diver-
sity and complexity, secondary metabolites exhibit an impressive
array of biological activities and may act as metal transporters,
toxins, bioregulators, antimicrobial agents, enzyme inhibitors, in-
secticides, and signaling compounds. The genes for their biosyn-
thetic pathways are typically clustered in the genome togetherwith
genes for resistance, export, and postassembly tailoring (2). Sec-
ondary metabolites are classified into different groups based on
their biosynthetic origin and chemical structure. These include
polyketides, terpenes, alkaloids, nonribosomal peptides, and
lipids.
The zeamines are a class of bioactive polyamine-polyketide-
nonribosomal peptide natural products produced by Serratia
plymuthica RVH1 (3–5). Zeamine and zeamine I consist of a spe-
cific valine-linked polyketide moiety, conjugated via an amide
bond to a common 40-carbon penta amino hydroxyalkyl chain
(zeamine II) (Fig. 1). The 50-kb zeamine biosynthetic gene cluster
has been identified in the genome of S. plymuthica RVH1 and
consists of 15 coding sequences. Besides tailoring and export-re-
lated enzymes, the gene cluster encodes two separate enzymatic
assembly lines for the biosynthesis of the polyamino alcohol chain
and the peptide-polyketide moiety (4). Recently, the pathway for
zeamine biosynthesis, which involves an unprecedented interac-
tion between nonribosomal peptide synthetase, type I modular
polyketide synthase, and polyunsaturated fatty acid synthase-like
biosynthetic machinery, was fully characterized (6). Zeamine and
zeamine II also have been reported as metabolites of the bacterial
phytopathogen Dickeya zeae EC1 (7), and homology searches in-
dicate that the biosynthetic gene cluster is conserved among sev-
eral other Enterobacteriaceae genera, e.g., Photorhabdus and Xe-
norhabdus.
All components of the zeamine complex are cationic at physi-
ological pH and exhibit potent bactericidal activity against a broad
spectrum of Gram-positive and Gram-negative bacteria, includ-
ing multidrug-resistant pathogens (8). The production of these
antibiotics in S. plymuthica RVH1 is quorum-sensing regulated
and provides the strain with a selective advantage in competitive
habitats, such as mixed-species biofilms (9, 10). Zeamine and
zeamine II also have been shown to play a major role in the viru-
lence ofD. zeae EC1, which causes rice foot rot andmaize stalk rot
diseases.D. zeaemutants defective in zeamine productionwere no
longer able to inhibit rice seed germination and growth. In addi-
tion, a reduced virulence on Chinese cabbage and potatoes was
observed (7).
In this study, we set out to investigate the specific mode of
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action that underlies the broad-spectrum bactericidal activity of
these novel chemical scaffolds.We analyzed the effect of the zeam-
ines on macromolecular synthesis in Escherichia coli and Staphy-
lococcus aureus and studied their effects at the single-cell level us-
ing time-lapse microscopy. We examined the interaction of the
zeamines with artificial phospholipid membranes of different
compositions by measuring the efflux of encapsulated carboxy-
fluorescein. The ability of the zeamines to cause outer membrane
(OM) permeabilization was characterized by comparing the up-
take of small hydrophobic and large hydrophilic probes in E. coli.
Our results suggest that the zeamines behave in a manner similar
to that of cationic antimicrobial peptides, disrupting the integrity
ofmembranes throughdirect electrostatic andhydrophobic inter-
actions with the phospholipid bilayer.
MATERIALS AND METHODS
Chemicals. Bacto tryptone and yeast extract were purchased from LabM
(Lancashire, United Kingdom). NH4SO2 and NaCl were purchased from
Acros Organics (Geel, Belgium). Radiolabeled precursors andMicroScint
were from PerkinElmer (Waltham, MA, USA). Solvents were obtained
from Acros Organics. Phospholipids were purchased from Avanti Polar
Lipids (Alabaster, AL, USA). All other chemicals were from Sigma-Al-
drich (St. Louis, MO, USA).
Strains and culturing conditions.E. coliMG1655 and S. aureusATCC
27661 were grown and maintained in lysogeny broth (LB) at 37°C. Over-
night cultures of Serratia sp. strains weremade in LB broth and incubated
at 30°C. For zeamine production, S. plymuthica RVH1 and the S. plym-
uthica RVH1zmn19 mutant (6) were grown in minimal medium (7)
[10.5 g/liter K2HPO4, 4.5 g/liter KH2PO4, 2 g/liter (NH4)2SO4, 2 g/liter
mannitol, 0.2 g/liter MgSO4.7H2O, 5 mg/liter FeSO4, 10 mg/liter CaCl2,
and 2 mg/liter MnCl2; pH 7.0] supplemented with 5 M synthetic N-(3-
oxo-hexanoyl)-C6-homoserine lactone at 16°C for 72 h on a rotary shaker
(80 rpm).
Production and isolation of the zeamine antimicrobial compounds.
Following fermentation of S. plymuthica RVH1, cells were removed by
centrifugation (4,000 g, 45 min). The supernatant was adjusted to pH
10.0 with 1 M NaOH and extracted with n-butanol twice. The organic
solvent was removed by rotary evaporation in vacuo. The dry extract was
redissolved in methanol (MeOH) containing 5% triethylamine, mixed
with three times the amount of silica, and allowed to dry overnight. The
silica powder then was added to the top of a silica column and washed
sequentially with MeOH-CH2Cl2 (1:8), MeOH-CH2Cl2 (1:4), MeOH-
CH2Cl2 (1:2), MeOH-CH2Cl2 (1:1), and 100% MeOH. The zeamines (a
mixture of zeamine, zeamine I, and zeamine II) eluted with MeOH con-
taining 1% formic acid. The fractions of interest were pooled and dried by
lyophilization. The dried solids were dissolved either inMeOHor inwater
for use in cellular assays. The purity of the isolated zeamine compounds
was verified by high-performance liquid chromatography (HPLC) and
nuclear magnetic resonance (NMR) as described previously (4). For the
production and isolation of zeamine II, the Serratia plymuthica
RVH1zmn19 mutant (6), deficient in the production of zeamine and
zeamine I, was used. Purification was done similarly to that for the zeam-
ine mixture.
Macromolecular synthesis assay. The effect of the zeamine antibiot-
ics on DNA, RNA, protein, and lipid synthesis was examined bymonitor-
ing the incorporation of radiolabeled precursors [(methyl-3H)-thymi-
dine, (5,6-3H)-uridine, L-(4,5-3H)-leucine, (2-3H)-glycerol]. Overnight
cultures ofE. coliMG1655 and S. aureusATCC27661were diluted 50-fold
in fresh medium and grown to midexponential growth phase (optical
density at 600 nm [OD600] of 0.3). The
3H-labeled precursors then were
added to the cells at a final concentration of 1 Ci/ml. The cultures were
divided into 96 Deep Well blocks (750 l/well) with a BREATHseal
(Greiner Bio One) on top and incubated at 37°C for 10 min. Amixture of
zeamine, zeamine I, and zeamine II (5 mg/ml stock solution in MilliQ
water) was subsequently added to the bacterial cultures in final concen-
trations equivalent to 0.5 and 0.25 the MIC. Negative controls were
supplemented with MilliQ water instead of antibiotics. Before and after
the addition of the zeaminemixture (timepoints of 0min, 10min, 20min,
30 min, 45 min, and 60 min), 100-l samples were taken from the cul-
tures, added to 100l ice-cold 10% trichloroacetic acid (TCA), and stored
at 4°C for 30 min. The TCA-precipitated samples were transferred to a
Unifilter-96 GF/C filter plate (PerkinElmer) by using a Filtermate 196
harvester (Packard). The filter plates were washed four times with 5%
TCA, four times with water, and once with 95% ethanol before being
dried for 1 min on a 60°C heat block. Finally, 10l MicroScint was added
to the plates, and scintillation was read with a TopCount NXTmicroplate
scintillation/luminescence counter (PerkinElmer). Experiments were
performed in triplicate.
Preparation of SUVs for CF efflux assays.Vesicles with the following
phospholipid compositions were prepared: (i) 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE)-1,2-dioleoyl-sn-glycero-3-phospho-(1=-
rac-glycerol) (DOPG) (1-1), (ii) DOPE-DOPG (8-2), and (iii) 1,2-dio-
leoyl-sn-glycero-3-phosphocholine (DOPC)-cholesterol (7-3). Stock
solutions (100 mM) of the phospholipids and the cholesterol were made
in distilled dichloromethane (DCM) and mixed at the appropriate molar
ratios. Solvents were evaporated under nitrogen flow and put in a vacuum
desiccator for 3 h to remove trace solvents. The resulting film was rehy-
drated with a 30 mM carboxyfluorescein (CF) solution in 5 mMHEPES-
NaOH buffer, pH 7.4. This solution was vigorously stirred for 15 h in the
dark at room temperature and subsequently sonicated at 0°C for 45min to
obtain small unilamellar vehicles (SUVs). Nonencapsulated CF was re-
moved from the liposomes by gel filtration (Sephadex G50 column).
Phospholipid concentrations were determined by the inorganic phos-
phate assay as described by Ames (11). The liposomes were stored at 4°C
and used within 48 h.
CF release assay. CF release from the SUVs upon exposure to a mix-
ture of zeamine, zeamine I, and zeamine II was evaluated. From a stock
solution of 5 mg/ml in MeOH, a 2-fold serial dilution of the zeamine
mixture was made in 5 mM HEPES-NaOH buffer, pH 7.4, at 10-fold
higher concentrations than the desired final concentration. Liposomal
stock preparations were diluted in the same buffer to a final concentration
FIG 1 Structures of zeamine (A), zeamine I (B), and zeamine II (C).
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of 25 M. Twenty l of zeamine solution then was added to 180 l of
liposomes in a microwell plate, and the increase in fluorescence intensity
was recorded every minute for 20 min in a Fluoroskan Ascent microplate
fluorometer (excitation wavelength [ex], 485 nm; emission wavelength
[em], 520 nm). As a negative control, buffer was used instead of antibi-
otics. After 20min, 20l of a 10%Triton X-100 solution was added to the
liposomes to solubilize the vesicles and release all trapped CF. The per-
centage of zeamine-induced CF leakage at time twas calculated as%CF
[F(t)  F(0)]/[F(T)  F(0)]  100, where F(0) is fluorescence intensity
before addition of zeamines, F(t) is the fluorescence intensity at time t in
the presence of zeamines, and F(T) is the fluorescence intensity after ad-
dition of Triton X-100 (12, 13). Two independent assays were performed,
during which each sample was tested in triplicate.
Cytostatic activity assay.Murine leukemia L1210, humanT-lympho-
cyte CEM, and human cervix carcinoma (HeLa) cells were suspended at
3  105 to 5  105 cells/ml of culture medium, and 100 l of a cell
suspensionwas added to 100l of an appropriate dilution of the zeamines
in wells of 96-well microtiter plates. After incubation at 37°C for two
(L1210) or three (CEM and HeLa) days, the cell number was determined
using a Coulter counter. The IC50 was defined as the compound concen-
tration required to inhibit cell proliferation by 50%.
Membrane integrity study with fluorescent dyes. Zeamine-induced
membrane damage was assessed with the LIVE/DEAD BacLight bacterial
viability kit (Molecular Probes). An overnight culture of E. coli MG1655
and S. aureus ATCC 27661 was diluted 1:100 in fresh medium and grown
to exponential growth phase (OD600 of 0.6). Cells were harvested by cen-
trifugation (4,000 g, 20min), washedwith 0.9%NaCl, and resuspended
in the samebuffer in 1:10 of their original volume.Cells subsequentlywere
diluted 1:20 in 0.9%NaCl containing different final concentrations equiv-
alent to 2 and 4 the MIC of the zeamine mixture (5 mg/ml stock
solution in MeOH). MeOH in equivalent concentrations was used as a
negative control. Bacteria and test compounds were incubated at room
temperature with continuous shaking for 15, 30, or 60 min before being
centrifuged at 4,000 g for 20 min. Pellets were washed with 0.9% NaCl
and resuspended in half of the previous volume. The resulting bacterial
suspension was mixed with the BacLight reagent (3 l/ml bacterial sus-
pension) and incubated in the dark at room temperature for 15min. Cells
were observed with a fluorescencemicroscope (Leica DMLBmicroscope;
McBain Instruments) at excitation/emission maxima of 480/500 nm
(Syto 9) and 490/635 nm (propidium iodide).
NPN uptake assay.Outer membrane permeabilization was evaluated
using the 1-N-phenylnaphtylamine (NPN) uptake assay as described pre-
viously (14). E. coli MG1655 was grown to exponential growth phase
(OD600 of 0.6) in LB medium at 37°C, washed with 5 mMHEPES-NaOH
(pH 7.2), and resuspended in the same buffer at two-thirds of the original
volume. Test substances included zeamine II (50 mg/ml stock solution in
MeOH) and a mixture of zeamine, zeamine I, and zeamine II (5 mg/ml
stock solution in MeOH). To assess a range of concentrations around the
MIC of the zeamine mixture (8 g/ml), serial dilutions of the test com-
pounds weremade in 5mMHEPES-NaOH buffer (pH 7.2). Polymyxin B
and kanamycin served as positive and negative controls, respectively, and
were dissolved in the same buffer. A 40 mM stock solution of NPN (Sig-
ma-Aldrich) was prepared in acetone and diluted to a concentration of 40
Min 5mMHEPES-NaOHbuffer (pH7.2). A 100-l volume of bacterial
suspension wasmixed in amicrowell plate with 50l of the test substance
(at a 3-fold higher concentration than the intended final concentration)
and incubated at 37°C. After 15 min, 50 l of NPN (40 M in 5 mM
HEPES-NaOH buffer [pH 7.2]) was added, and fluorescence was read
within 3 min. Fluorescence was measured in a Fluoroskan Ascent micro-
plate fluorometer (ex, 355 nm; em, 405 nm; Thermo Labsystems). Op-
tical densities were recorded immediately thereafter with a Multiskan RC
(Thermo Labsystems) at 600 nm. Control samples included (i) bacterial
suspension (100 l), buffer (50 l), and NPN (50 l); (ii) bacterial sus-
pension (100 l), test substance (50 l), and buffer (50 l); (iii) bacterial
suspension (100l) and buffer (100l); (iv) buffer (150l) andNPN (50
l); and (v) buffer (200l).Methanol was included in the buffer in equiv-
alent concentrations when used as a control for the zeamine test com-
pounds. Each sample was tested in triplicate, and independent assays were
performed twice. The results were expressed as relative NPN uptake fac-
tors (the NPN uptake factor calculated for the test substance, subtracted
from the NPN uptake factor calculated for cells without the test sub-
stance). To calculate the NPN uptake factor for the test substance, the
fluorescence values of the bacterial suspension with the test substance and
NPNwere divided by the corresponding optical densities and background
corrected by subtracting the fluorescence values of control samples with-
out NPN (ii), which were equally divided by their corresponding OD
values. The resulting values were then divided by the fluorescence values
of the buffer to give the uptake factor. The NPN uptake factor for the cells
without test substance was calculated accordingly using the values from
control samples containing buffer instead of test substance (i and iii).
PBDKZ-GFP uptake assay. To examine outer membrane permeabil-
ity, a fusion protein consisting of the high-affinityN-terminal peptidogly-
can binding domain of endolysin KZ144 (PBDKZ) from Pseudomonas
aeruginosa bacteriophage KZ and green fluorescent protein (PBDKZ-
GFP) was used (15–17). Bacterial suspensions of E. coli MG1655 were
prepared as described for the NPN uptake assay. A mixture of zeamine,
zeamine I, and zeamine II (10 mg/ml stock solution in MeOH) was used
for the assay. To test a range of concentrations around the MIC of the
zeaminemixture (8g/ml), a dilution series of the antibioticswasmade in
5 mM HEPES-NaOH buffer (pH 7.2) in concentrations that were 4-fold
higher than the desired final concentration. One hundred microliters of
the bacterial suspension was mixed in a microwell plate with 50 l of the
zeamine mixture and 50 l PBDKZ-GFP (final concentration, 0.2 g/l).
Samples were incubated at room temperature for 15 min. Cells subse-
quently were collected by centrifugation (13,000  g, 10 min), washed
twice in 5 mM HEPES-NaOH, pH 7.2, and resuspended in the same
buffer. The fluorescence of PBDKZ-GFP was measured in a Fluoroskan
Ascent microplate fluorometer (ex, 485 nm; em, 520 nm; Thermo Lab-
systems). Optical densities were recorded immediately thereafter with a
MultiskanRC (ThermoLabsystems) at 600 nm.Control samples included
bacterial suspension (100l), buffer (50l), and PBDKZ-GFP (50l) (i);
bacterial suspension (100 l), zeamines (50 l), and buffer (50 l) (ii);
bacterial suspension (100 l) and buffer (100 l) (iii); buffer (100 l),
zeamines (50 l), and PBDKZ-GFP (50 l) (iv); and buffer (200 l) (v).
Methanol was included in the buffer in equivalent concentrations when
used as a control for the zeamine mixture. Each sample was tested 3-fold,
and independent assays were performed twice. Cells treated with a chlo-
roform-saturated 0.05 M Tris-HCl, pH 7.7, buffer were used as a positive
control (18). The results were expressed as relative uptake factors, which
were calculated as described for the NPN uptake assay.
Time-lapse microscopy.Overnight cultures of E. coliMG1655 grown
in LB orMmedium (19) were diluted 1:100 in fresh medium and spotted
on an LB/Mmedium agar pad containing different final concentrations of
the zeamine mixture. Subsequently, the growth of single cells was re-
corded in real time at 37°C for 4 h with a temperature-controlled (Okolab
Ottaviano) Ti-Eclipse inverted microscope (Nikon) equipped with a TI-
CT-E motorized condensor and a CoolSnap HQ2 FireWire charge-cou-
pled device (CCD) camera. Images were acquired using NIS Elements AR
3.2 software (Nikon) as described previously (20) and further handled
with Fiji open source software (downloaded from http://fiji.sc/Fiji).
RESULTS
Rapid and simultaneous inhibition of macromolecular synthe-
sis in E. coli and S. aureus upon exposure to subinhibitory con-
centrations of zeamines. To determine which macromolecular
processes are affected by the zeamines, the effect of the antibiotics
on the incorporation of [3H]thymidine, [3H]uridine, [3H]leucine,
and [3H]glycerol was examined in E. coli MG1655. A copurified
mixture of zeamine, zeamine I, and zeamine II was added to mid-
exponential-phase cultures at a concentration of 4g/ml (MIC, 8
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g/ml) (6). Within 20 min, this resulted in the complete and si-
multaneous inhibition of DNA, RNA, protein, and fatty acid bio-
synthesis (Fig. 2). In the presence of 2 g/ml of the zeamine mix-
ture, intermediate inhibition was observed. Comparable effects
and kinetics were observed in assays with S. aureus (data not
shown). The rate and lack of specificity in the inhibition of the
macromolecular processes at low dose indicate that DNA, RNA,
protein, and fatty acid biosynthesis are not a primary target of the
zeamines and suggest that the inhibition is an indirect effect of a
more general action of these antimicrobial metabolites. The long,
hydrophobic backbone of the zeamines, along with their broad
spectrumof activity, led us to investigate their impact on the phys-
ical integrity of membranes.
The zeamines cause nonspecificmembrane damage in direct
interaction with phospholipid bilayers. To study the interaction
of the zeamine antibiotics with phospholipid bilayers, the release
of carboxyfluorescein (CF) from small unilamellar vesicles
(SUVs) wasmonitored (12, 13). As long as CF is entrapped within
the SUVs, its fluorescence emission is autoquenched due to a high
local concentration. However, when the integrity of the mem-
brane is disrupted, orwhen the permeability is increased as a result
of membrane phase rearrangement, CF dilutes into the environ-
ment, resulting in prominent fluorescence. SUVs with different
phospholipid compositions (phosphatidylethanolamine/phos-
phatidylglycerol [PE/PG] ratio of 1:1, PE/PG ratio of 8:2, and
phosphatidylcholine/cholesterol [PC/Ch] ratio of 7:3) were pre-
pared tomimic the cytoplasmicmembrane of Gram-positive bac-
teria, Gram-negative bacteria, and human erythrocytes, respec-
tively (21). The addition of increasing amounts of the zeamine
mixture, ranging from 1 g/ml to 32 g/ml, caused rapid and
immediate concentration-dependent CF leakage from both types
of PE/PG SUVs tested, followed by a period of slower CF release
(Fig. 3). The zeamines were slightly more effective on the PE/PG
8:2 SUVs than on the PE/PG 1:1 vesicles. In contrast, liposomes
made of PC/Ch were less affected by the zeamine mixture (	50%
release). These results demonstrate the ability of the zeamines to
directly interactwith bacterialmodelmembranes in the absence of
a specific receptor and to permeabilize the phospholipid bilayer.
Despite the lower selectivity for eukaryotic model membranes,
significant cytostatic activity was observed against murine leuke-
mia cells (L1210), human T-lymphocyte cells (CEM), and human




 0.1 M, respectively.
Nonspecific membrane damage following zeamine exposure
was confirmed in cultures of S. aureus ATCC 27661 and E. coli
MG1655 using the Live/Dead BacLight bacterial viability kit. Flu-
orescence microcopy revealed that, in contrast to untreated cells,
both cultures uniformly exhibited red fluorescence following
treatment with 16 and 32g/ml of the zeaminemixture, revealing
damage to the cytoplasmic membrane (data not shown).
Zeamine exposure results in subtle disruption of the outer
membrane rather than drastic perturbations or defined pore
formation. Given the antimicrobial activity of the zeamines
against Gram-negative bacteria, we subsequently examined the
effect of the antibiotics on the permeability of the outer mem-
brane. This was evaluated by monitoring the uptake of the fluo-
FIG 2 Impact of the zeamines on the biosynthesis of proteins (A), RNA (B), fatty acids (C), andDNA (D) in E. coliMG1655. CPM, counts perminute. Cells were
incubated with the antibiotics at concentrations of 2 and 4 g/ml (MIC, 8 g/ml) from time zero. Data are represented as means
 standard deviations from
triplicate experiments.
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rescent probe NPN (14, 22). NPN is a small lipophilic dye which
fluoresces strongly in hydrophobic environments and only weakly
in aqueous environments. The outer leaflet of the outer mem-
brane is composedmainly of lipopolysaccharide (LPS)molecules,
which act as a permeability barrier to external lipophilic sub-
stances, like NPN (23). However, when membrane integrity is
disrupted, e.g., through the action of amembrane-permeabilizing
compound, NPN partitions into the hydrophobic lipid interior of
the outer and inner membrane, which results in a strong increase
in fluorescence. Exponentially growing E. coliMG1655 was incu-
bated with a mixture of zeamine, zeamine I, and zeamine II in
different final concentrations, ranging from1g/ml to 128g/ml.
After 15 min, NPN was added and the samples were read for flu-
orescence. Polymyxin B, a known membrane-permeabilizing
agent, and kanamycin added at their respectiveMIC values served
as a positive and negative control, respectively. The effect of zeam-
ine exposure onNPNuptake by E. coli is shown in Fig. 4 as relative
NPN uptake factors. The antibiotics clearly affect the integrity of
the outer membrane and facilitate NPN uptake to an extent
similar to that of polymyxin B. Zeamine-induced membrane
permeabilization is dose dependent, requiring a minimum
concentration of 2 g/ml. Maximum NPN uptake was ob-
tained at the MIC (8 g/ml) (6), and uptake values slowly
decreased again at concentrations well above the MIC. Mem-
brane permeabilization also was observed when E. coli was in-
cubated with zeamine II alone, albeit at higher concentrations
of the antibiotic (Fig. 4). Concentrations above 16 g/ml were
required to induce NPN uptake, and the highest uptake value
was obtained after treatment with 64 g/ml zeamine II. This is
in agreement with the lower antimicrobial activity of zeamine
II against E. coli (MIC, 64 g/ml) (6) and suggests that the
valine-linked polyketide moiety that is missing in zeamine II
plays an important role in OM destabilization.
The ability of the zeamines to facilitate the uptake of larger
probes was evaluated by using the hydrophilic fluorescent fusion
protein PBDKZ-GFP, consisting of the N-terminal peptidoglycan-
binding domain of endolysin KZ144 (PBDKZ) from Pseudomonas
aeruginosa phage KZ fused to GFP (15). Normally, PBDKZ-GFP
cannot access its peptidoglycan substrate unless the outer mem-
brane is drastically damaged. In this case, the fusion protein binds
A1 chemotype peptidoglycan with high affinity. As a conse-
quence, the measured fluorescence intensity directly correlates
with the extent of membrane permeabilization. PBDKZ-GFP has
been used successfully as a tool to evaluate outer membrane per-
meabilizing agents (16) and to visualize and quantify pressure-
induced permeability changes in P. aeruginosa PAO1 (17). In this
experiment, exponentially growing E. coliMG1655 was incubated
with PBDKZ-GFP and different concentrations of the zeamine
mixture. After 15 min, any unbound probes were washed away
and fluorescence was recorded. The results, represented as relative
uptake factors, are shown in Fig. 5. Unlike the NPN assay, no
PBDKZ-GFP uptake was observed at concentrations of up to 16
g/ml. A minimum dose of 32 g/ml was required to measure
FIG 3 Zeamine-induced CF leakage from PE/PG 1:1 (A), PE/PG 8:2 (B), and
PC/Ch 7:3 (C) SUVs. Antibiotics were added at time zero in different final
concentrations, ranging from 1 g/ml to 32 g/ml. The SUV concentration
was 25 M.
FIG 4 Effect of different concentrations of a mixture of zeamine, zeamine I,
and zeamine II (dark gray bars) and zeamine II alone (light gray bars) on NPN
uptake by E. coliMG1655. Cells treated with kanamycin (32 g/ml) and poly-
myxin B (1 mg/ml) (white bars) served as negative and positive controls, re-
spectively. The results are expressed as relative NPN uptake factors.
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fluorescence, and maximal fluorescence was recorded after treat-
ment with 64 g/ml (8 MIC). However, visualization by fluo-
rescencemicrocopy revealed that the cells were not homogenously
labeledwith the probe, contrary to the control chloroform-treated
cells (Fig. 6A). Instead, fluorescence originated from aggregates of
probe trapped in cellular debris and probe bound to the pepti-
doglycan of lysed cells (Fig. 6B andC). This phenomenon also was
observed with cells treated with 1 mg/ml polymyxin B (data not
shown) and explains the elevated uptake PBDKZ-GFP values com-
pared to those for chloroform-treated cells. Thus, exposure to
high concentrations of zeamines results in membrane solubiliza-
tion and lysis. These results are consistent with the decline inNPN
uptake values observed at the same doses, as discussed in the pre-
vious section.
Time-lapse microscopy reveals morphological changes. To
study the effect of the zeamines at the single-cell level, cell growth
and morphological changes of E. coliMG1655 were monitored in
the presence of antibiotics using time-lapsemicroscopy. Exposure
to zeamines at concentrations of 8 g/ml completely blocked cell
growth, whereas a concentration of 16 g/ml led to membrane
lysis during both cell division and cell growth. Although cells be-
came slightly more spherical, an intact sacculus remained. This
indicates that peptidoglycan integrity is not affected and suggests
that the lysis is a direct consequence of membrane permeabiliza-
tion (Fig. 7A). Interestingly, when a similar experiment was per-
formed in M medium, a medium with higher osmolarity (19), a
reversible plasmolysis-like phenomenon took place instead of ly-
sis. The cytoplasm shrunk, putatively linked to intracellular con-
tent loss, and the cytoplasmic membrane detached from the cell
wall. Although this shrinking process appeared to be transient, the
cells did not resume growth (Fig. 7B).
DISCUSSION
This work focused on determining the specific mode of action of
the zeamines and identifying their molecular target. Our data re-
veal that the zeamines cause nonspecific membrane damage in
target Gram-positive and Gram-negative bacteria. DNA, RNA,
protein, and fatty acid biosynthesis ceased rapidly and simultane-
ously in the presence of 0.5MIC of zeamines. This is likely the
result of leakage of cellular components ormembrane depolariza-
tion, causing the depletion of precursors and energy required for
these biosynthetic processes. In addition, zeamine treatment may
affect the conformation of certain membrane-bound proteins by
inducingmembrane phase rearrangements. Thismay in turn trig-
ger signal transduction pathways involved in the regulation of
macromolecular processes. The ability of the zeamines to induce
carboxyfluorescein leakage from small unilamellar vesicles indi-
cates that they can permeabilize membranes through direct inter-
action with the phospholipid bilayer and that no receptor-medi-
ated recognition is required. Their higher selectivity for bacterial
over eukaryotic model membranes seems to be related to the
phospholipid composition and net surface charge of the vesicles.
Bacterial phospholipids such as phosphatidylglycerol are nega-
tively charged, facilitating interactionwith cationic substances like
the zeamines. On the other hand, eukaryotic membranes consist
predominantly of zwitterionic phosphatidylcholine and contain
cholesterol, which makes the membrane more rigid (24). Despite
their lower affinity for artificial eukaryotic membranes, the zeam-
ines were found to exhibit potent antiproliferative activity against
murine and human cancer cell lines, with IC50s in the 1.7 to 4.1
M range. The zeamines also were shown to disrupt the Gram-
negative OM, facilitating the uptake of the small hydrophobic
FIG 5 Zeamine-induced PBDKZ-GFP uptake by E. coli MG1655 (dark gray
bars). Cells treated with polymyxin B (1 mg/ml) and a chloroform-saturated
Tris-HCl buffer (white bars) were used as a positive control. Results are rep-
resented as relative PBDKZ-GFP uptake factors.
FIG 6 (A) Fluorescence microscopy of E. coli MG1655 homogeneously labeled with PBDKZ-GFP following treatment with a chloroform-saturated 0.05 M
Tris-HCl (pH 7.7) buffer. (B) Phase-contrast/fluorescence overlay image of E. coliMG1655 in the presence of PBDKZ-GFP and the zeaminemixture at 32g/ml.
Gray areas represent lysed cells. (C) The corresponding fluorescence microscopy image. Zeamine treatment caused aggregates of the probe to become trapped
within cellular debris.
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probe NPN in a dose-dependent manner. The concentrations re-
quired to induce NPN uptake were in the same range as those that
evoke CF release. It is interesting that a higher concentration of
zeamine II was required to induce NPN uptake than that for the
zeamine mixture. This is consistent with the lower antimicrobial
activity of zeamine II and suggests that the valine-linked
polyketidemoiety plays an important role in the destabilization of
the OM. Presumably, this moiety enables stronger or other inter-
actionswithOMconstituents, facilitating the integration of zeam-
ine and zeamine I into the membrane. The fact that the bulky
hydrophilic fusion protein PBDKZ-GFP was not able to cross the
OM and bind to its peptidoglycan substrate upon zeamine expo-
sure under the tested conditions points to subtle alterations of the
OM rather than drastic perturbations or discrete pore formation.
At concentrations well above the MIC, the zeamines were shown
to inducemembrane solubilization and lysis.Detailed observation
of morphological changes in zeamine-treated E. coli cells using
time-lapse microscopy confirmed that at concentrations equiva-
lent to 2MIC, cell lysis occurred. Since the affected cells retain
an intact peptidoglycan sacculus, this is believed to be a conse-
quence of membrane permeabilization. In medium with higher
osmolarity, cells displayed transient plasmolysis-like effects upon
zeamine exposure.
Both structurally and functionally, the zeamines share similar-
ities with cationic antimicrobial peptides (CAMPs). CAMPs are a
large group of bioactive peptides produced by virtually all species
of life as a major part of their primary defense system (25, 26). In
addition to their broad spectrumof activity against bacteria, fungi,
parasites, viruses, and even cancer cells, they display a variety of
immunomodulatory effects (27). CAMPs typically are between 12
and 50 amino acids in length. They are rich in hydrophobic resi-
dues and contain an excess of basic lysine and arginine residues,
which confer a net positive charge of2 to9 (28). Upon contact
with lipid bilayers, CAMPs adopt various amphipathic structures
that form the basis for their mode of action (29). They cross the
OM of Gram-negative bacteria by interacting with the negatively
charged phosphate groups of the LPS layer and competitively dis-
placing the native stabilizing divalent cations. This causes local
disruptions and enables translocation across theOM. TheCAMPs
then bind to the anionic lipid head groups of the cytoplasmic
membrane and insert themselves into the outer leaflet, parallel to
the plane of the bilayer, leading to the displacement of lipids.
Through hydrophobic interactions, they subsequently insert
themselves into the membrane interior (25). Similar to the zeam-
ines, CAMPs exhibit a strong preference for negatively charged
bacterial over zwitterionic eukaryoticmembranes.Differentmod-
els have been proposed to explain the process of membrane dis-
ruption, including the carpet, the toroidal pore, the barrel-stave,
and the aggregate model (30–33). CAMPs effect their bactericidal
action either by direct interference with the physical integrity of
the membrane (membrane lysis), by inhibition of membrane-
associated processes like cell division, peptidoglycan biosyn-
thesis, or energy generation, or by translocation across the cy-
toplasmic membrane and interaction with (polyanionic)
intracellular targets, such as DNA, RNA, or certain phosphor-
ylated proteins (25, 28). CAMPs often combine several of the
aforementioned mechanisms, targeting multiple processes
with low affinity rather than interacting with one specific target
with high affinity (34).
Given the presence of several primary amino and hydroxyl
groups evenly distributed across the hydrophobic backbone, the
zeaminesmight be able to adopt amembrane-bound amphipathic
secondary structure in a manner similar to that of CAMPs. We
speculate that the positively charged amino groups interact with
the polyanionic LPS, inducing local perturbations that allow the
zeamines to pass the OM. Contact with the cytoplasmic mem-
brane likely is initiated through electrostatic interactions as well.
The positively charged amino groups may be oriented toward the
negatively charged phospholipid head groups, while the hydro-
phobic backbone is buried in the fatty acid portion. The additional
positive charge present in the valine-derived moiety of zeamine
and zeamine I might contribute to the stabilization of the interac-
tion with the outer and/or cytoplasmic membrane. Upon inser-
tion into the interior of the membrane, the zeamines could span
the entire bilayer given their length. The possibility that these an-
timicrobial metabolites subsequently cross the cytoplasmic mem-
brane and interact with a secondary intracellular target cannot be
excluded at this stage. Future molecular dynamics simulations
and membrane modeling studies may shed more light on the sec-
ondary structure adopted by the zeamines and on the precise mo-
lecular events that occur upon contact with the cell envelope. The
potent, broad-spectrum activity of the zeamines against Gram-
negative and Gram-positive bacteria, including multidrug-resis-
tant pathogens, makes them attractive candidates for clinical drug
development. However, their activity on eukaryotic model mem-
branes, although reduced compared to that on bacterial artificial
membranes, might limit them to topical rather than systemic ap-
plications. Further experiments are in progress to investigate rates
and mechanisms of resistance development against the zeamine
antibiotics.
FIG 7 Time-lapse series of the effect of the zeamines on E. coli MG1655. (A)
Upon exposure to the zeamine antibiotics at 2MIC (16g/ml), cells became
slightly more spherical before losing their cell content. An intact sacculus re-
mained, suggesting that membrane integrity rather than peptidoglycan integ-
rity was affected. (B) In Mmedium, a medium with higher osmolarity, zeam-
ine treatment (32 g/ml) caused a transient plasmolysis-like effect, inducing
shrinking of the cytoplasm (white arrowheads). The scale bar indicates 4 m.
Time points (in minutes:seconds) are indicated.
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